NASDAQ · Medical - Instruments & Supplies

MBOT (MBOT) Stock

$1.68 -3.45% NASDAQ: MBOT Healthcare

Valuation

MetricValue
Price$1.68
Market Cap$76.56M
P/E Ratio-6.38
P/B Ratio1.08
P/S Ratio776.87
EPS (TTM)$-0.29
52-Week High$4.67
52-Week Low$1.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-16.67%
ROA-15.85%
ROCE-19.23%
Gross Margin-9.52%
Operating Margin-152.78%
Net Margin-94.21%
Debt/Equity0.01
Current Ratio26.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-11.0M$-13.0M$-10.0M$-12.0M$-15.0M
Net Profit$-11.0M$-13.0M$-11.0M$-11.0M$-13.0M
EPS$-1.59$-1.81$-1.05$-0.73$-0.29
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$17.0M$10.0M$8.0M$6.0M$82.0M
Total Liabilities$2.0M$2.0M$4.0M$3.0M$4.0M
Cash$13.0M$3.0M$2.0M$3.0M$4.0M
Borrowings$1.0M$0$0$0$1.0M

Latest News

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026 GlobeNewswire · Jul 7, 2026 Why Is Sanmina (SANM) Stock Soaring Today StockStory · Jun 30, 2026 Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader GlobeNewswire · Jun 30, 2026 Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System GlobeNewswire · Jun 25, 2026 Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System GlobeNewswire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-9.0M$-12.0M$-9.0M$-9.0M$-13.0M
Investing Cash Flow$3.0M$-4.0M$2.0M$2.0M$-72.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-6.0M$-11.0M$0$1.0M$1.0M
Free Cash Flow$-9.0M$-12.0M$-9.0M$-9.0M$-13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-18.85%
Quick Ratio21.93
Interest Coverage—
Return 1Y-24.53%
Return 3Y-24.22%
Return 5Y-73.11%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLNNClene Inc. $5.29 -1.86% -1.66 $54.53M 0.00%
CNTX $0.62 +4.47% -6.84 $56.69M 0.00%
CRDL $1.36 +1.49% -3.38 $156.77M 0.00%
DCGO $0.65 +2.91% -0.33 $64.18M 0.00%
NSPR $0.69 +0.87% -1.21 $32.30M 0.00%

About MBOT

MBOT is led by CEO Harel Gadot, publicly traded since 1992.

MBOT stock trades at $1.68 with a market capitalization of $76.56M. The stock is valued at a price-to-earnings (P/E) ratio of -6.38, price-to-book of 1.08, price-to-sales of 776.87. Over the past 52 weeks the stock has ranged between $1.60 and $4.67, and currently trades 64.0% below its 52-week high.

On profitability, MBOT generates a return on equity (ROE) of -16.67%, return on capital employed of -19.23%, an operating margin of -152.78%, a net profit margin of -94.21%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides